NanoVibronix (NAOV) said Friday it completed its acquisition of privately-held ENvue Medical Holdings in a stock-for-stock transaction.
Under the deal, all of ENvue's outstanding equity interests were exchanged based on a fixed exchange ratio for consideration as a combination of about 1.7 million NanoVibronix common shares and 57,720 shares of series X non-voting convertible preferred stock, NanoVibronix said.
The company said that after the completion of the deal, a successor-in-interest of ENvue will be a wholly-owned unit of NanoVibronix.
The company also said concurrently with the deal's closing, it sold a $500,000 senior convertible debenture in a private placement.
NanoVibronix shares were up nearly 2% in recent trading.
Price: 0.48, Change: +0.01, Percent Change: +1.93
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。